Live Broadcast Announcement: 1st International Expert Forum on Small Intestinal Bacterial Overgrowth (SIBO)

August 20, 2024, by the Asian Neurogastroenterology and Motility Association (ANMA)Initiated by “International Expert Forum on Small Intestinal Bacterial Overgrowth” is about to be grandly convened.This forum brings together leading experts and scholars in the field of gastroenterology from both China and abroad, sharing insights through various formats such as academic presentations and panel discussions.Small Intestinal Bacterial Overgrowth(SIBO) Diagnosis and Treatment Experience, Exploring Frontier Achievements in SIBO, Aiming to Strengthen International Academic Exchange and Cooperation, and Promote High-Quality Development of Gastroenterology.

“Digestive Medical Voice” will provide a live broadcast of the entire forum. Experts, scholars, and industry colleagues are welcome to watch and engage in exchanges!

Hangzhou Leyi Biotechnology Co., Ltd. wholly owns three subsidiaries: Lewei Health, Leya Biotechnology, and Maishuo Medical. Specializing in the research and innovation of cutting-edge biotechnologies for breath molecular diagnostics, the company is dedicated to the rapid diagnosis and early screening of diseases across multiple systems, including the digestive system. It operates as an integrated enterprise encompassing R&D, manufacturing, marketing, and services.

Bioleya, an independently developed brand under its portfolio^®(Leya) ExhaleGas Analyzer, is the first product approved for marketing in China that adopts the “fixed + gas chromatography” methodology and simultaneously complies with the international “gold standard”*with China’s “National Standard”*Dual-certified methane andHydrogen Breath TestDetection devices. Currently widely used in clinical practice, Chinese expert consensus is being developed to deepen disciplinary applications, standardize industry norms, and facilitate technological innovation.